April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Vessel diameter and retinopathy in the Inter99 Eye Study
Author Affiliations & Notes
  • Dragana Drobnjak
    Ophthalmology, Oslo University Hospital, Ullevaal, Oslo, Norway
  • Nina Veiby
    Ophthalmology, Oslo University Hospital, Ullevaal, Oslo, Norway
  • Torben Jørgensen
    Research Center for Prevention and Health, Glostrup, Denmark
  • Line Kessel
    Ophthalmology, Glostrup Hospital, Glostrup, Denmark
  • Michael Larsen
    Ophthalmology, Glostrup Hospital, Glostrup, Denmark
  • Inger Munch
    Ophthalmology, Roskilde Hospital, Copenhagen, Denmark
  • Footnotes
    Commercial Relationships Dragana Drobnjak, None; Nina Veiby, None; Torben Jørgensen, None; Line Kessel, None; Michael Larsen, None; Inger Munch, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5327. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Dragana Drobnjak, Nina Veiby, Torben Jørgensen, Line Kessel, Michael Larsen, Inger Munch; Vessel diameter and retinopathy in the Inter99 Eye Study. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5327.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To examine the relationship between retinal vessel diameters and retinal microangiopathy in healthy and diabetic subjects.

Methods: The study population of the Inter99 study comprised an age- and sex-stratified sample of 13.016 participants residing in 11 suburban municipalities of the south-western part of Copenhagen Country. Of 6784 subjects aged 30-60 years who participated in the main study, a subgroup of 970 subjects participated in the eye study. Digital fundus photos were taken at the baseline examination. Subjects with ungradeable images were excluded. 935 participants were graded for retinopathy according to the ETDRS standard. Vessel diameters were expressed as central retinal artery equivalent diameter (CRAE), and central retinal vein equivalent diameter (CRVE). Multivariate analyses was used to compare data sets.

Results: CRAE decreased with increasing systolic blood pressure (p<0.0001) and with increasing age (p<0.001). CRAE was increased in subjects with known diabetes mellitus. CRAE increased with 4.2 µm (CI95%:1.1-7.4, p=0.0079) in subjects with retinopathy compared to subjects without retinopathy adjusting for age, sex, glucose regulation and systolic blood pressure in all subjects (n=935). CRVE decreased with increasing age (p=0.0365). CRVE increased with 4.57 µm (CI95%: 0.19-8.9, p=0.041) in subjects with retinopathy compared to subjects without retinopathy adjusting for age, sex, glucose regulation and systolic blood pressure in all subjects. In participants without diabetes mellitus CRAE and CRVE increased with 1 µm in subjects with retinopathy compared to subjects without retinopathy, but not significantly. In participants with diabetes mellitus, CRAE increased significantly with 6.5 µm (CI95% 1.17-11.9, p=0.017) in subjects with retinopathy compared to subjects without retinopathy. In participants with diabetes mellitus CRVE increased significantly with 7.8 µm (CI95% 0.33-15.3, p=0.041) in subjects with retinopathy compared to subjects without retinopathy.

Conclusions: Wider retinal arterial and vein diameters were significantly associated with retinopathy in subjects with diabetes mellitus. Development of better and newer approaches to retinal vascular imaging is needed to raise the power of detection and the accuracy of quantification of retinal microvascular changes. This development may help to understand the pathology and association between elements leading to retinopathy progression.

Keywords: 465 clinical (human) or epidemiologic studies: systems/equipment/techniques • 688 retina • 499 diabetic retinopathy  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×